AbbVie (ABBV) Acquires Apogee Therapeutics for $10.9 Billion

AbbVie (ABBV) Acquires Apogee Therapeutics for $10.9 Billion  GuruFocus

Summary aggregated from GuruFocus's public RSS feed. The full reporting belongs to GuruFocus — please read it on their site.